Eric Joseph Daniels is Chief Development Officer of KIORA PHARMACEUTICALS INC. Currently has a direct ownership of 18,577 shares of KPRX, which is worth approximately $69,292. The most recent transaction as insider was on Jul 01, 2024, when has been sold 7,355 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.6K
0% 3M change
78.97% 12M change
Total Value Held $69,292

Eric Joseph Daniels Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 01 2024
BUY
Grant, award, or other acquisition
-
7,355 Added 28.36%
18,577 Common Stock
Jun 14 2024
BUY
Open market or private purchase
$7,569 $5.29 p/Share
1,431 Added 11.31%
11,222 Common Stock
Sep 29 2023
BUY
Grant, award, or other acquisition
-
62,500 Added 41.44%
88,338 Common Stock
Mar 03 2023
BUY
Grant, award, or other acquisition
-
15,600 Added 37.65%
25,838 Common Stock
Oct 21 2022
BUY
Grant, award, or other acquisition
-
10,000 Added 49.41%
10,238 Common Stock
EJD

Eric Joseph Daniels

Chief Development Officer
Salt Lake City, UT

Track Institutional and Insider Activities on KPRX

Follow KIORA PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPRX shares.

Notify only if

Insider Trading

Get notified when an Kiora Pharmaceuticals Inc insider buys or sells KPRX shares.

Notify only if

News

Receive news related to KIORA PHARMACEUTICALS INC

Track Activities on KPRX